论文部分内容阅读
目的对新辅助化疗在宫颈癌治疗中的应用进行分析。方法把我院所接收的60例宫颈癌患者随机分成两组,每组30例,其中一组直接采用手术治疗,称之为对照组;另外一组采用新辅助化疗,之后再确定相应的治疗方法,称之为观察组。最后对两组患者的病灶大小以及血清SCC水平变化情况进行对比。结果观察组患者治疗前后的病灶大小变化情况比较差异具有统计学意义(P<0.05);对照组患者治疗前后的病灶大小变化情况比较差异不具有统计学意义(P>0.05);其中观察组患者的血清SCC水平化疗前后比较差异具有统计学意义(P>0.05)。结论新辅助化疗在宫颈癌治疗中,可以对患者的病灶大小进行有效的缩小,降低血清SCC水平。
Objective To analyze the application of neoadjuvant chemotherapy in the treatment of cervical cancer. Methods Sixty cases of cervical cancer received by our institute were randomly divided into two groups, 30 cases in each group. One group was directly treated by surgery, which was called as control group. The other group was treated by neoadjuvant chemotherapy and then the corresponding treatment Method, called the observation group. Finally, the two groups of patients with lesion size and serum SCC levels were compared. Results Before and after treatment, the changes in the size of the lesions in the observation group were statistically significant (P <0.05); the changes in the size of the lesions in the control group before and after treatment were not statistically significant (P> 0.05); in the observation group Serum SCC levels before and after chemotherapy were statistically significant differences (P> 0.05). Conclusion Neoadjuvant chemotherapy in the treatment of cervical cancer, the patient’s lesion size can be effectively reduced, lower serum SCC levels.